Obermatt

Ensign Group

NSQ:ENSG · US29358P1012
Health Care Providers & ServicesLarge

360

65
EV / EBIT33
Price / Owner Earnings28
Owner Earnings Yield51
Dividend Yield71
Price/Sales17
EV / Gross Profit26
Price/Book25
Return on Capital63
Cash Return on Capital66
Return on Equity76
EBIT Margin35
Gross Profitability43
Cash Conversion41
Accruals26
Owner Earnings Margin59
Sales growth70
Profit Growth70
Long-Term EPS Growth77
Owner Earnings Growth63
Reinvestment75
Price momentum58
Debt load53
Refinancing47
Debt Payback56
Liquidity100
Analyst ratings52
Opinion Changes50
Price Target Upside91
Market mood100
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Ensign Group clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
TypePublic Company
ExchangeNASDAQGS
Founded1999
Employees125
ISINUS29358P1012
Last UpdateApr 2, 2026
Themes
Health DiagnosticsCardiovascularAssisted LivingRespiratoryOutpatient CareNeurologyChronic DiseasesHealth CareMedicalService Industry

Description

The Ensign Group, Inc., together with its subsidiaries, provides skilled nursing, senior living and rehabilitative services, as well as other ancillary businesses (including mobile diagnostics and medical transportation), in 17 states. As part of th…

Analysis

Middle-of-the-road

The Ensign Group, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 29.8× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 12% yearly growth; analysts expect 15%. The price, in other words, assumes less than the experts do.

The trajectory is solid and the balance sheet is adequate. The company scores 10/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
96
2023202420252026

All-time high

100

Jan 2025

All-time low

54

Feb 2026

Average rank

93

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
17
31
27
43
Price/Earnings
36
46
36
41
Price/Book
25
30
19
31
Dividend Yield
71
72
75
75
Value (overall)
34
62
43
56

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Ensign Group with its peers
Addus
NSQ:ADUS
96
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Select Medical
NYQ:SEM
41
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Encompass
NYQ:EHC
69
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Extendicare
TOR:EXE
93
CountryCanada
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Community Health Systems
NYQ:CYH
23
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
National Research
NSQ:NRC
43
CountryUSA
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →